Biomedical entrepreneurship in U.S. regions
Biomedical entrepreneurship in U.S. regions
复制标题
DOI：
10.1007/s10961-023-09996-8
复制
发表时间：
2023-02
期刊：
影响因子：
--
通讯作者：
Sang-Min Park;Nicholas S. Vonortas
中科院分区：
文献类型：
--
作者：
Sang-Min Park;Nicholas S. Vonortas
创业生态系统研究者通常关注影响创业的少数主导因素。对创业生态系统内各区域条件之间的相互依存关系重视不够。我们专注于区域生物医药创业因素的集体效应。我们使用模糊集定性比较分析（fsQCA）方法来确定美国所有381个大都市区促进生物医学创业的区域条件集。结果表明，三种结构有助于高水平的区域生物医学创业：第一个结合公共部门的生物医学R&D，生物医学专利，人力资本，从而强调科学条件和相关的人力资本;第二个结合公共部门的生物医学R&D，生物医学专利，临床试验，风险资本，从而更加强调区域基础设施支持创业活动;第三种模式将私营部门生物医学研发、生物医学专利、人力资本、人均收入、人口密度和风险资本结合起来，从而强调私营部门在促进区域生物医学创业方面的作用。一个区域要提高其生物医学创业水平，没有单一的方法。
Entrepreneurial ecosystem researchers generally focus on the few dominant factors affecting entrepreneurship. Insufficient attention has been paid to the interdependencies among regional conditions within an entrepreneurial ecosystem. We focus on the collective effects of factors for regional biomedical entrepreneurship. We use the fuzzy-set qualitative comparative analysis (fsQCA) method to identify sets of regional conditions promoting biomedical entrepreneurship in all 381 U.S. metropolitan areas. The results indicate three configurations contributing to high levels of regional biomedical entrepreneurship: the first one combines public sector biomedical R&D, biomedical patents, and human capital, thus stressing science conditions and related human capital; the second combines public sector biomedical R&D, biomedical patents, clinical trials, and venture capital, thus placing more emphasis on the regional infrastructure sustaining entrepreneurial activity; the third combines private sector biomedical R&D, biomedical patents, human capital, per capita income, population density, and venture capital, thus emphasizing the private sector’s role on boosting regional biomedical entrepreneurship. There is no single recipe for a region to increase its level of biomedical entrepreneurship.